2-(Tert-Butyl)-5-Phenyl-4-((4-(Piperidin-1-Yl)Phenyl)Amino)Isothiazol-3(2H)-One 1,1-Dioxide 2-(叔丁基)-5-苯基-4-((4-(哌啶-1-基)苯基)氨基)异噻唑-3(2H)-酮-1,1-二氧化物
CAS 898800-26-5 MFCD98800265
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. van der Hoorn J et al. Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels.
- Br J Pharmacol. 2011 Apr;162(7):1553-63.
- Eur J Heart Fail. 2015 Mar;17(3):273-82.
- Eur J Heart Fail. 2015 Mar;17(3):273-82.
- [1]. Cannon MV et al. The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects.
- [1]. Cannon MV et al. The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects.
- [2]. van der Hoorn J et al. Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels.